ArticleJournal of the American Heart Association2026
EAT-Lancet Diet, Plasma Metabolites, and Risk of Peripheral Artery Disease: A Prospective Cohort Study.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Planetary Health Diet Index, developed by the EAT-Lancet Commission, promotes sustainable and healthy eating, yet its association with peripheral artery disease (PAD) remains underexplored. Furthermore, the metabolic mechanisms potentially linking this dietary pattern to PAD warrant deeper investigation.
methodsIn 192 166 UKB (UK Biobank) participants with 24-hour dietary recall, Cox proportional hazards models were used to evaluate the association between the EAT-Lancet diet index and PAD. In a subcohort (n=93 961), diet-related metabolites were identified via elastic net regression to construct a metabolic signature, which was analyzed for its association with PAD risk and potential mediating role.
resultsOver a median follow-up of 10.55 years, 1579 PAD events occurred. Higher adherence to the EAT-Lancet diet was associated with a lower PAD risk (hazard ratio [HR], 0.74 [95% CI, 0.62-0.87]), consistent across subgroups and sensitivity analyses. Sixty metabolites formed the diet-related metabolic signature, inversely associated with PAD (HR, 0.66 [95% CI, 0.50-0.88]) and mediating 12.9% (95% CI, 4.6%-28.5%) of the diet's protective effect, with mediating metabolites mainly enriched in the fatty acids subclass.
conclusionsGreater adherence to the EAT-Lancet diet is associated with a lower risk of PAD, with its metabolic signature potentially mediating this relationship, underscoring the importance of dietary interventions and metabolic monitoring for PAD prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.